Category: Jim’s Corner
BIO CEO Lays out Vision for Future of Industrial Biotech
During the opening plenary lunch at BIO’s World Congress on Industrial Biotechnology, Jim Greenwood, President …
BIO and Biominas Brasil to Co-Host 2014 BIO Latin America Conference
I am excited to announce that BIO will co-host a new conference event, BIO Latin …
Physician Payments Sunshine Act: Collaboration Key for Doctors & Biopharmas
In a letter to the editor on USA Today, BIO CEO Jim Greenwood and John …
Biotech Investors, Emerging Companies Bullish On 2014
The 16th BIO CEO & Investor Conference is off to a great start. This event …
FDA Week: For Biologics, A Name Isn't Just A Name (Jim Greenwood op-ed)
What is in a name? Names help make medicinal products more easily distinguishable by doctors, …
Stable Policy Can Help Assure Unwavering Investment in U.S. Biofuels
The Renewable Fuel Standard (RFS) is a unique federal policy that has, just as its …
Congress Passes Omnibus Spending Agreement
This week, BIO President and CEO Jim Greenwood praised the Congress for passing the fundingbill …
BIO Joins Partners for Healthy Dialogues
The Biotechnology Industry Organization (BIO) recently joined the Partners for Healthy Dialogues effort. Dialogues+ had …
BIO President & CEO Presents Dr. Cohen With Lifetime Achievement Award
Last week, Jim Greenwood, President & CEO of the Biotechnology Industry Organization (BIO), attended the …
A Manhattan Project for Alzheimer's Disease
Earlier this month, at the Alzheimer’s Disease Summit in New York City, BIO‘s President & …